Metformin use and long-term risk of benign prostatic hyperplasia: a population-based cohort study

OBJECTIVE: To assess whether metformin use affects risk of benign prostatic hyperplasia (BPH) by comparing the risk of BPH in men with type 2 diabetes who initiated first-line treatment with either metformin or sulfonylurea monotherapy between 2000 or 2006 in Northern Denmark. In this period, sulfon...

Descripción completa

Detalles Bibliográficos
Autores principales: Nørgaard, Mette, Darvalics, Bianka, Thomsen, Reimar Wernich
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Urology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7757457/
https://www.ncbi.nlm.nih.gov/pubmed/33371039
http://dx.doi.org/10.1136/bmjopen-2020-041875

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7757457/
https://www.ncbi.nlm.nih.gov/pubmed/33371039
http://dx.doi.org/10.1136/bmjopen-2020-041875

Ejemplares similares